Search results
Results from the Health.Zone Content Network
On 27 August 2021, India crossed the milestone of administering more than 10 million (1 crore) doses of COVID-19 vaccine in a single day, setting a new world record. Uttar Pradesh topped the list with 2.8 million doses, followed by Karnataka with 1 million doses and Maharashtra at third with 0.98 million doses.
Vaccination policy. India's Universal Immunization Programme (UIP) began in 1985. The UIP covers: [1] [2] [3] BCG vaccine for Tuberculosis. DPT vaccine for Diphtheria, Pertussis and Tetanus. OPV vaccine for Poliomyelitis. Measles vaccine / Measles and Rubella vaccine. Hepatitis B vaccine. TT vaccine.
Universal Immunisation Programme ( UIP) is a vaccination programme launched by the Government of India in 1985. [1] It became a part of Child Survival and Safe Motherhood Programme in 1992 and is currently one of the key areas under the National Health Mission since 2005. The programme now consists of vaccination for 12 diseases- tuberculosis ...
Here are vaccines you may need for travel to India: Hepatitis A. This disease can be transmitted through food and water. The risk for Hepatitis A in India is high. So, immunization is highly ...
25 December 2014. ( 2014-12-25) Status. Active. Website. nhp.gov.in. Mission Indradhanush is a health mission of the Government of India. It was launched by Union Health Minister J. P. Nadda on 25 December 2014. [1] The scheme this seeks to drive towards 90% full immunisation coverage of India and sustain the same by year 2022.
A vaccination schedule is a series of vaccinations, including the timing of all doses, which may be either recommended or compulsory, depending on the country of residence. A vaccine is an antigenic preparation used to produce active immunity to a disease , in order to prevent or reduce the effects of infection by any natural or "wild" pathogen ...
The preferred vaccination schedule involves 2 doses of the recombinant zoster vaccine (RZV, Shingrix) over 2 to 6 months, rather than 1 dose of the older live zoster vaccine (ZVL, Zostavax).
A total of 1,268 healthy participants between the age of 18 and 80 years to be selected from 15 sites across India for the trial and intended to be part of a larger global Phase III study. [13] [11] On 3 June 2021, India's Ministry of Health and Family Welfare pre-ordered 300 million doses.